BNGO — Bionano Genomics, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1411690 ·
Last close
$1.66
Market Cap
$19.55M
52W High
$2.23
52W Low
$1.00
ADV30
1,762,483
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 8,171,000 | 4,314,000 | -7,218,000 | -7,423,000 | 47,591,000 | 3,730,000 | 15,985,000 |
| Mar 2026 | 6,687,000 | 3,252,000 | -7,897,000 | -8,303,000 | 64,804,000 | 3,425,000 | 27,341,000 |
| Dec 2025 | 7,951,000 | 3,399,000 | -8,536,000 | -7,933,000 | 73,584,000 | 2,990,000 | 29,160,000 |
| Sep 2025 | 7,367,000 | 3,370,000 | -8,538,000 | -8,503,000 | 79,062,000 | 3,065,000 | 29,263,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-19,297,000
Investing CF
$6,776,000
Financing CF
$13,805,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.36
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-727,923,000
Inventory
$5,307,000
Receivables
$4,133,000
ST Investments
$10,980,000
EBIT TTM
$-30,397,000
Pretax Income TTM
$-31,527,000
Interest Exp TTM
$1,130,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$30,176,000
EBITDA
$-22,873,000
Free Cash Flow
$2,347,750
Enterprise Value
$11,152,940
Total Cash
$9,919,000
Total Debt
$6,704,000
Shares Out
11,777,000
Trailing EPS
$-3.01
Book Value
$2.68
ROE
-83.6%
ROA
-32.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 28,508,000 | -33,339,000 | -26,395,000 | 73,584,000 | 29,160,000 | 44,424,000 | -16,345,000 |
| Dec 2024 | 30,776,000 | -76,278,000 | -112,017,000 | 76,670,000 | 41,295,000 | 35,375,000 | -68,922,000 |
| Dec 2023 | 36,116,000 | -137,224,000 | -232,493,000 | 214,404,000 | 118,247,000 | 96,157,000 | -125,181,000 |
| Dec 2022 | 27,802,000 | -131,698,000 | -132,596,000 | 307,502,000 | 58,104,000 | 249,398,000 | -124,816,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$29,069,000
NetIncome TTM
$-191,723,000
OpCashFlow TTM
$0
Assets (Latest)
$73,584,000
Forward EPS
$-0.97
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GNVR | Genvor Inc | $19.62M | $1.00 | — |
| MAPPF | PROSTAR HOLDINGS INC. /BC | $19.38M | $0.12 | — |
| PSQH | PSQ Holdings, Inc. | $19.75M | $5.30 | — |
| ALGRF | KENADYR METALS CORP | $19.90M | $0.47 | — |
| NNUP | NOCOPI TECHNOLOGIES INC/MD/ | $19.95M | $1.70 | — |
News headlines (Yahoo Finance, 1h cache)
Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
2026-09-23 13:00 · Yahoo
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
2026-09-10 13:00 · Yahoo
Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping
2026-09-08 13:00 · Yahoo
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-24 12:00 · Yahoo
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript
2026-08-17 21:14 · Yahoo
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ...
2026-08-11 05:03 · Yahoo
Bionano Reports Second Quarter 2026 Results and Provides a Business Update
2026-08-10 20:05 · Yahoo
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
2026-07-27 20:05 · Yahoo
Bionano Announces Hiring of Chief Scientific Officer
2026-06-24 12:30 · Yahoo
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
2026-06-18 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.